Yan Tang1, Yingtao Wu1, Ziyi Huang1, Weiwei Dong1, Ying Deng1, Fengjiao Wang1, Ming Li2, Jieli Yuan3. 1. Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian, China. 2. Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian, China. Electronic address: Vivianmarat@163.com. 3. Department of Microecology, College of Basic Medical Science, Dalian Medical University, Dalian, China. Electronic address: zgwst@126.com.
Abstract
OBJECTIVE: The use of probiotics to alleviate chemotherapy-induced intestinal mucositis is supported by clinical consensus. However, no studies to date, to our knowledge, have systematically analyzed the effects of a probiotic mixture on chemotherapy-induced mucositis or assessed changes in the intestinal microbiota after probiotic treatment. The aim of this study was to report the effects of a probiotic mixture, DM#1, on intestinal mucositis and dysbiosis of rats treated with 5-fluorouracil (5-FU). METHODS: Twenty-eight male Sprague Dawley rats weighing 180 to 220 g were randomly divided into four groups: control, 5-FU, probiotic high (PH), and probiotic low (PL). Except for the control group, all other groups received intraperitoneal injections of 5-FU for 5 d, and the PH and PL groups received DM#1 intragastrically (1 × 109 or 1 × 108 colony-forming units/kg, respectively) for 8 d. One day after the last administration, rats were sacrificed and the ilea were removed for histopathologic assessment and evaluation of permeability, myeloperoxidase activity, levels of cytokines (interleukin [IL]-4, IL-6, tumor necrosis factor [TNF]-α), and mRNA of toll-like receptors (TLR; TLR2, TLR4, and TLR9). Additionally, intestinal microbiota profiles were analyzed by polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis and quantitative real-time PCR. RESULTS: Treatment with DM#1 ameliorated 5-FU-induced intestinal mucosal injury in rats, possibly by reducing proinflammatory cytokine levels and neutrophil infiltration. The increased intestinal permeability caused by 5-FU was ameliorated. These results were closely associated with the reestablishment of intestinal microbial homeostasis and alteration of the TLR2/TLR4 signaling pathway. CONCLUSIONS: Administration of the probiotic mixture DM#1 ameliorated 5-FU-induced intestinal mucositis and dysbiosis in rats. Copyright Â
OBJECTIVE: The use of probiotics to alleviate chemotherapy-induced intestinal mucositis is supported by clinical consensus. However, no studies to date, to our knowledge, have systematically analyzed the effects of a probiotic mixture on chemotherapy-induced mucositis or assessed changes in the intestinal microbiota after probiotic treatment. The aim of this study was to report the effects of a probiotic mixture, DM#1, on intestinal mucositis and dysbiosis of rats treated with 5-fluorouracil (5-FU). METHODS: Twenty-eight male Sprague Dawley rats weighing 180 to 220 g were randomly divided into four groups: control, 5-FU, probiotic high (PH), and probiotic low (PL). Except for the control group, all other groups received intraperitoneal injections of 5-FU for 5 d, and the PH and PL groups received DM#1 intragastrically (1 × 109 or 1 × 108 colony-forming units/kg, respectively) for 8 d. One day after the last administration, rats were sacrificed and the ilea were removed for histopathologic assessment and evaluation of permeability, myeloperoxidase activity, levels of cytokines (interleukin [IL]-4, IL-6, tumornecrosis factor [TNF]-α), and mRNA of toll-like receptors (TLR; TLR2, TLR4, and TLR9). Additionally, intestinal microbiota profiles were analyzed by polymerase chain reaction (PCR)-denaturing gradient gel electrophoresis and quantitative real-time PCR. RESULTS: Treatment with DM#1 ameliorated 5-FU-induced intestinal mucosal injury in rats, possibly by reducing proinflammatory cytokine levels and neutrophil infiltration. The increased intestinal permeability caused by 5-FU was ameliorated. These results were closely associated with the reestablishment of intestinal microbial homeostasis and alteration of the TLR2/TLR4 signaling pathway. CONCLUSIONS: Administration of the probiotic mixture DM#1 ameliorated 5-FU-induced intestinal mucositis and dysbiosis in rats. Copyright Â
Authors: Jean Guy LeBlanc; Alejandra de Moreno de LeBlanc; Romina Levit; Graciela Savoy de Giori Journal: Appl Microbiol Biotechnol Date: 2020-02-28 Impact factor: 4.813
Authors: Nina Dias Coelho-Rocha; Luís Cláudio Lima de Jesus; Fernanda Alvarenga Lima Barroso; Tales Fernando da Silva; Enio Ferreira; José Eduardo Gonçalves; Flaviano Dos Santos Martins; Rodrigo Dias de Oliveira Carvalho; Debmalya Barh; Vasco Ariston de Carvalho Azevedo Journal: Probiotics Antimicrob Proteins Date: 2022-08-26 Impact factor: 5.265
Authors: Richard A Forsgård; Vannina G Marrachelli; Katri Korpela; Rafael Frias; Maria Carmen Collado; Riitta Korpela; Daniel Monleon; Thomas Spillmann; Pia Österlund Journal: Cancer Chemother Pharmacol Date: 2017-06-23 Impact factor: 3.333
Authors: Bárbara F Cordeiro; Emiliano R Oliveira; Sara H da Silva; Bruna M Savassi; Leonardo B Acurcio; Luisa Lemos; Juliana de L Alves; Helder Carvalho Assis; Angélica T Vieira; Ana M C Faria; Enio Ferreira; Yves Le Loir; Gwénaël Jan; Luiz R Goulart; Vasco Azevedo; Rodrigo D de O Carvalho; Fillipe L R do Carmo Journal: Front Microbiol Date: 2018-09-12 Impact factor: 5.640